Procarbazine is a type of medicine used to treat certain kinds of cancer, like Hodgkin's disease. It's often given with other drugs as part of a specific treatment plan. It works by interfering with cancer cell growth.
Every report comes from a Lived member, sent anonymously.
Have you tried Matulane (Procarbazine) for Oligodendroglioma?
Procarbazine, sold in the US as Matulane, is a chemotherapy medicine taken by mouth. Its approved use is advanced Hodgkin lymphoma, meaning stage III or IV disease, in adults and children. It is never used on its own: it is one part of a combination of cancer drugs, most often a regimen called BEACOPP or, in the past, one called MOPP, each combining several other chemotherapy drugs with the steroid prednisone. Many people with Hodgkin lymphoma today receive combinations that do not include procarbazine, so whether it is part of a plan depends on the stage, risk features and the overall treatment approach. Procarbazine is also used outside its approved label in a brain tumor regimen called PCV (procarbazine, lomustine and vincristine). Expert guidelines recommend radiation plus PCV for adults newly diagnosed with oligodendroglioma, a type of glioma defined by specific genetic changes, and list PCV as one chemotherapy option for some other lower-grade gliomas.
Procarbazine belongs to a group of chemotherapy drugs called alkylating agents, which damage the genetic material (DNA) inside cells. The body first converts procarbazine into active forms. These are thought to interfere with the cell's ability to make proteins and to produce reactive molecules that damage DNA directly, although the exact mechanism has never been fully worked out. The result is that cancer cells stop growing or die. Healthy cells are affected too, especially the blood-forming cells of the bone marrow, which is why blood counts drop during treatment. Procarbazine also has a second, unrelated property: it blocks monoamine oxidase (MAO), an enzyme that breaks down certain chemical messengers and substances from food. This is not how it fights cancer, but it explains several of its food and drug interactions.
Matulane comes as capsules taken by mouth, usually once a day, with or without food. The dose is calculated from body surface area, which is worked out from height and weight, and adjusted to the specific regimen. In combination treatment it is typically taken on a set run of days within each treatment cycle, with breaks that give the bone marrow time to recover, so the calendar from the oncology team is the guide rather than a fixed daily routine. The team may pause or stop procarbazine if blood counts fall too low or if side effects such as nerve symptoms, painful mouth sores or diarrhea develop. If a dose is missed, take it when remembered unless the next dose is nearly due, and never take two doses together. Procarbazine is classed as a hazardous drug, so follow the pharmacy's instructions for handling and disposing of the capsules, and keep them away from children and other household members.
Nausea and vomiting are among the most common effects. Other frequent complaints include loss of appetite, tiredness, constipation, dry mouth, trouble sleeping, headache, hair loss and aches in muscles or joints. Because procarbazine is given with other cancer drugs, some effects come from the combination as a whole. The most important effect is on the bone marrow. Procarbazine commonly lowers white cells, red cells and platelets, often 2 to 8 weeks after starting, which raises the risk of infection, anemia and bleeding. Call the care team right away for fever, chills or other signs of infection, unusual bleeding or bruising, black tarry stools, red urine, or new shortness of breath or exhaustion. Procarbazine can also affect the nervous system. Tingling or numbness in the hands or feet, unsteadiness, confusion, hallucinations, vision changes, fainting or a seizure should be reported to the care team right away. So should painful mouth sores, severe or ongoing diarrhea, or yellowing of the skin or eyes. A true allergic reaction is uncommon, but it means procarbazine is stopped for good. Hives, rash or itching call for a prompt call to the care team; trouble breathing or swallowing needs emergency help.
Alcohol is off limits. Procarbazine can cause a reaction to alcohol with flushing, headache, nausea, vomiting and stomach cramps. The label advises avoiding alcohol, including beer and wine, and products containing propylene glycol (an additive a pharmacist can help identify) before, during and after treatment, so ask how long that period lasts for you. Because procarbazine blocks MAO, combining it with other medicines that also block MAO can cause a dangerous spike in blood pressure. These include MAO inhibitor antidepressants such as phenelzine (Nardil), the Parkinson's medicine selegiline and the antibiotic linezolid. They need to be stopped at least two weeks before starting procarbazine and avoided during treatment, so mention any of them to the oncology team, including one another doctor prescribes later. Foods high in tyramine, a substance found in certain cheeses and some other foods, can trigger the same kind of spike, so ask for a written list of foods to avoid. Other sedating medicines, including some over-the-counter allergy medicines, can add to drowsiness and nervous-system effects. Give the team a full list of prescriptions, nonprescription products and supplements, and check before starting anything new. Procarbazine can harm a developing baby. A pregnancy test is done before starting, women who could become pregnant should use effective contraception during treatment, and so should men whose partner could become pregnant. Tell the care team right away about a known or suspected pregnancy. Breastfeeding is not advised during treatment. Regimens containing procarbazine are among those most strongly linked to infertility, including stopped sperm production and early loss of ovarian function, and the effect can be permanent. Freezing sperm or eggs before treatment is the main way to preserve fertility, so it is worth raising before the first cycle. Treatment also raises the long-term risk of second cancers, such as leukemia and lung cancer, and smoking adds to the lung cancer risk. People with kidney or liver disease need closer monitoring, and anyone who recently had radiation or other chemotherapy usually waits about a month before starting.
Procarbazine is taken in cycles alongside the other drugs in the regimen, for a planned number of cycles (four to eight is common in Hodgkin lymphoma regimens that include it). Expect frequent blood tests, often weekly, along with urine, liver and kidney tests. The results decide whether the next cycle starts on time or is delayed or adjusted. The alcohol and food rules apply for the whole course, which takes some planning around meals and social events. How well treatment works depends on the cancer, its stage and the full regimen rather than on procarbazine alone. In Hodgkin lymphoma, a positron emission tomography (PET) scan, an imaging test that shows where cancer is still active, partway through treatment often helps decide whether therapy can be shortened or needs to change. Follow-up continues for years after treatment ends, partly to watch for late effects such as the second cancers described under Interactions & Warnings, which can appear years later.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Matulane (Procarbazine), what you've noticed, or ask the community a question.